findmyKOL
Clinical trialNCT01849250CompletedPhase 2Interventional

Study of Docosahexaenoic Acid (DHA) in Triple Negative Breast Cancer Survivors

SponsorNational Cancer Institute (NCI)Enrollment65Benign Breast NeoplasmDuctal Breast Carcinoma In SituInvasive Breast CarcinomaLobular Breast Carcinoma In SituPaget Disease of the BreastStage IA Breast Cancer+6 more conditions
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

This randomized phase II trial studies how well docosahexaenoic acid works in preventing recurrence in breast cancer survivors. Docosahexaenoic acid supplement may prevent recurrence in breast cancer survivors.
clinicaltrials.gov ↗

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

4 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Dana-Farber Cancer Institute

    Boston, Massachusetts, United States

  • Columbia University/herbert Irving Cancer Center

    New York, New York, United States

  • Memorial Sloan-Kettering Cancer Center

    New York, New York, United States

  • Md Anderson Cancer Center

    Houston, Texas, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

The drug and biological interventions registered on this study, normalized to their RxNorm ingredient where possible.

Docosahexaenoate
Linked drugs open the directory filtered to KOLs working with them.clinicaltrials.gov ↗

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
31 May 2013
Primary completion
11 Jan 2016
Completion
22 Apr 2020
Last update posted
28 Dec 2021
Registered enrollment
65
Registry id
NCT01849250
clinicaltrials.gov ↗

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.